| Product Name |
Semaglutide |
|---|---|
| CAS No. | 910463-68-2 |
| MF | C187H291N45O59 |
| MW | 4113.58 |
| Purity | ≥98.0% |
| Appearance | White to off-white lyophilized powder |
| Packing | 1kg/bag,25kg/drum |
| Apply |
GLP-1 receptor agonist for type 2 diabetes management and weight loss therapy |
Semaglutide is a synthetic GLP-1 (glucagon-like peptide-1) analog designed to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite. With its long-acting pharmacokinetic profile, it is administered once weekly, offering improved compliance over daily GLP-1 analogs.
In addition to its role in type 2 diabetes treatment, Semaglutide has gained global attention for its effectiveness in chronic weight management. Clinical trials have shown significant reductions in HbA1c levels and body weight.
Key Benefits
High potency and specificity for GLP-1 receptor
Improves glycemic control with low risk of hypoglycemia
Promotes significant and sustainable weight loss
Long half-life allowing weekly dosing
Proven cardiovascular benefits in high-risk patients
High purity peptide synthesis using advanced solid-phase peptide synthesis (SPPS) technology
GMP-compliant production with strict peptide quality control
Endotoxin and residual solvent tests ensure safety for injectable formulations
Flexible customization for research, clinical, and formulation needs
| Specification | Qualified Testing Result | Actual Testing Result | Test Method |
|---|---|---|---|
| Part 1. Physical & Chemical Analysis | |||
| Appearance | White to off-white lyophilized powder | Complied | Visual |
| Solubility | Freely soluble in water | Complied | Visual |
| Purity (HPLC) | ≥98.0% | 99.1% | HPLC |
| Peptide Content | ≥80% | 82.4% | HPLC |
| Water Content | ≤5.0% | 3.8% | USP <921> |
| Acetate Content | ≤10% | 8.7% | HPLC |
| Part 2. Heavy Metal Analysis & Chemical Control | |||
| Total Heavy Metals | ≤10 ppm | Complied | AAS |
| Lead (Pb) | ≤3 ppm | <0.5 ppm | ICP-MS |
| Arsenic (As) | ≤1 ppm | <0.1 ppm | ICP-MS |
| Cadmium (Cd) | ≤1 ppm | <0.05 ppm | ICP-MS |
| Mercury (Hg) | ≤0.1 ppm | <0.01 ppm | ICP-MS |
| Part 3. Microbiological Analysis & Control | |||
| Total Plate Count (cfu/g) | ≤1,000 | <100 | USP <61> |
| Yeast & Mold (cfu/g) | ≤100 | <10 | USP <61> |
| E. coli | Negative | Negative | USP <62> |
| Salmonella (per 25 g) | Negative | Negative | USP <62> |
Active pharmaceutical ingredient (API) for anti-diabetic and anti-obesity drugs
Clinical research on metabolic disorders
Formulation into lyophilized powder for injection
Development of novel GLP-1 combination therapies
1kg/aluminium foil bag, with two plastic bags inside.
Gross Weight: 1.5kg Size: 18cmxH27cm
25kg/fiber drum, with two plastic bags inside.
Gross Weight: 28kg Size: 42cmxH52cm Volume: 0.0625mg/Drum.
DHL / FEDEX / EMS / E-PACKET / BY AIR / BY SEA
1. ≤50kg, Express delivery(DHL /FEDEX) recommended, usually called as DDU service;
2. ≤500kg, Air shipping recommended, usually called as CIF service;
3. >500kg, sea shipping recommended, usually called as FOB, CFR, or CIF service;
4. For high value products, please select air shipping and express delivery for safe.
We will contact you within 1 working day, please pay attention to the email with the suffix “forrest@oriherb.com”.
